Literature DB >> 24343841

Lamotrigine use in patients with binge eating and purging, significant affect dysregulation, and poor impulse control.

Mary Ellen Trunko1, Terry A Schwartz, Enrica Marzola, Angela S Klein, Walter H Kaye.   

Abstract

OBJECTIVE: Some patients with symptoms of binge eating and purging are successfully treated with specific serotonin reuptake inhibitors (SSRIs), but others experience only partial or no benefit. Significant affect dysregulation and poor impulse control may be characteristics that limit responsiveness.
METHOD: We report on the treatment of five patients with bulimia nervosa (BN), anorexia nervosa-binge/purge type (AN-B/P) or eating disorder not otherwise specified (EDNOS), using the anticonvulsant lamotrigine after inadequate response to SSRIs.
RESULTS: Following addition of lamotrigine to an antidepressant in four cases, and switch from an antidepressant to lamotrigine in one case, patients experienced substantial improvement in mood reactivity and instability, impulsive drives and behaviors, and eating-disordered symptoms. DISCUSSION: These findings raise the possibility that lamotrigine, either as monotherapy or as an augmenting agent to antidepressants, may be useful in patients who binge eat and purge, and have significant affect dysregulation with poor impulse control.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  anorexia nervosa; anticonvulsants; binge eating; bulimia nervosa; dangerous behavior; eating disorder; impulsive behavior; lamotrigine; self-destructive behavior; self-injurious behavior

Mesh:

Substances:

Year:  2013        PMID: 24343841     DOI: 10.1002/eat.22234

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  9 in total

1.  Is the pharmacological management of bulimia nervosa plausible?

Authors:  Guido K W Frank
Journal:  Expert Opin Pharmacother       Date:  2020-08-09       Impact factor: 3.889

2.  Temporal associations between affective instability and dysregulated eating behavior in bulimia nervosa.

Authors:  Laura A Berner; Ross D Crosby; Li Cao; Scott G Engel; Jason M Lavender; James E Mitchell; Stephen A Wonderlich
Journal:  J Psychiatr Res       Date:  2017-04-26       Impact factor: 4.791

Review 3.  Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa.

Authors:  Susan L McElroy; Anna I Guerdjikova; Nicole Mori; Francisco Romo-Nava
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

Review 4.  Reply to Skokou, M. Comment on "Keeler et al. Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review. Nutrients 2021, 13, 4158".

Authors:  Johanna Louise Keeler; Janet Treasure; Mario F Juruena; Carol Kan; Hubertus Himmerich
Journal:  Nutrients       Date:  2022-05-19       Impact factor: 6.706

Review 5.  Comment on Keeler et al. Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review. Nutrients 2021, 13, 4158.

Authors:  Maria Skokou
Journal:  Nutrients       Date:  2022-05-19       Impact factor: 6.706

6.  A pilot open series of lamotrigine in DBT-treated eating disorders characterized by significant affective dysregulation and poor impulse control.

Authors:  Mary Ellen Trunko; Terry A Schwartz; Laura A Berner; Anne Cusack; Tiffany Nakamura; Ursula F Bailer; Joanna Y Chen; Walter H Kaye
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2017-10-08

7.  Evaluating the use of lamotrigine to reduce mood lability and impulsive behaviors in adults with chronic and severe eating disorders.

Authors:  Erin E Reilly; Laura A Berner; Mary Ellen Trunko; Terry Schwartz; Leslie K Anderson; Angeline Krueger; Xinze Yu; Joanna Y Chen; Anne Cusack; Tiffany Nakamura; Walter H Kaye
Journal:  Eat Weight Disord       Date:  2022-03-17       Impact factor: 3.008

8.  Changes in cognitive and behavioral control after lamotrigine and intensive dialectical behavioral therapy for severe, multi-impulsive bulimia nervosa: an fMRI case study.

Authors:  Laura A Berner; Erin E Reilly; Xinze Yu; Angeline Krueger; Mary Ellen Trunko; Leslie K Anderson; Joanna Chen; Alan N Simmons; Walter H Kaye
Journal:  Eat Weight Disord       Date:  2021-10-18       Impact factor: 3.008

9.  Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosa.

Authors:  L M Huckins; K Hatzikotoulas; L Southam; L M Thornton; J Steinberg; F Aguilera-McKay; J Treasure; U Schmidt; C Gunasinghe; A Romero; C Curtis; D Rhodes; J Moens; G Kalsi; D Dempster; R Leung; A Keohane; R Burghardt; S Ehrlich; J Hebebrand; A Hinney; A Ludolph; E Walton; P Deloukas; A Hofman; A Palotie; P Palta; F J A van Rooij; K Stirrups; R Adan; C Boni; R Cone; G Dedoussis; E van Furth; F Gonidakis; P Gorwood; J Hudson; J Kaprio; M Kas; A Keski-Rahkonen; K Kiezebrink; G-P Knudsen; M C T Slof-Op 't Landt; M Maj; A M Monteleone; P Monteleone; A H Raevuori; T Reichborn-Kjennerud; F Tozzi; A Tsitsika; A van Elburg; D A Collier; P F Sullivan; G Breen; C M Bulik; E Zeggini
Journal:  Mol Psychiatry       Date:  2017-07-25       Impact factor: 15.992

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.